Ainos AIMDW

Jump To Section

    $

    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    .
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0

    Relative Strength Index (RSI)

    - The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

    - The RSI is calculated using the following formula:

    RSI = 100 - (100 / (1 + RS))

    Where RS is the ratio of the average gains to the average losses over a specified period.

    - The default time period used is 14 days.

    - RSI values range between 0 and 100.

    RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

    RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

    RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

    No daily data currently available, please try a different date range.

    About

    Business overview of Ainos (AIMDW)
    Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

    Key Insights

    Critical company metrics and information

    • Latest Closing Price

      $0.114

    • Price-Earnings Ratio

      -0.07

    • Total Outstanding Shares

      13.81 Million Shares

    • Total Employees

      46

    • Dividend

      No dividend

    • IPO Date

      August 5, 2022

    • SIC Description

      Pharmaceutical Preparations

    • Primary Exchange

      NASDAQ

    • Type

      Warrant

    • Headquarters

      Ainos, inc., San diego, CA, 92108

    • Homepage

      https://www.ainos.com

    Historical Stock Splits

    Execution DateSplit Amount
    No Historical Stock Splits

    Cash Flow Statement

    January 1, 2024 to December 31, 2024
    MetricValue
    Net Cash Flow From Financing Activities$8.03 Million
    Net Cash Flow$2.09 Million
    Net Cash Flow From Financing Activities, Continuing$8.03 Million
    Net Cash Flow From Investing Activities, Continuing$-125,292
    Net Cash Flow, Continuing$2.09 Million
    Net Cash Flow From Operating Activities$-5.81 Million

    Income Statement

    January 1, 2024 to December 31, 2024
    MetricValue
    Net Income/Loss Attributable To Parent$-14.86 Million
    Net Income/Loss Attributable To Noncontrolling Interest$0
    Net Income/Loss Available To Common Stockholders, Basic$-14.86 Million
    Cost Of Revenue$52,595
    Diluted Average Shares$9.50 Million
    Preferred Stock Dividends And Other Adjustments$0

    Comprehensive Income

    January 1, 2024 to December 31, 2024
    MetricValue
    Comprehensive Income/Loss Attributable To Parent$-15.00 Million
    Comprehensive Income/Loss$-15.00 Million
    Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
    Other Comprehensive Income/Loss$-15.00 Million

    Balance Sheet

    January 1, 2024 to December 31, 2024
    MetricValue
    Other Non-current Assets$174,418
    Intangible Assets$23.75 Million
    Noncurrent Assets$24.48 Million
    Current Assets$4.34 Million
    Noncurrent Liabilities$9.35 Million
    Equity Attributable To Parent$15.52 Million

    Historical Dividends

    Announcement DatePayment DateRecord DateAmountFrequency
    No historical dividends

    Recent Headlines From The Web

    Latest news, press releases, and media coverage about AIMDW from trusted financial sources
      Boost your savings and earn 4.15% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
      All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

      ⓒ 2025 Financhle. All Rights Reserved.